Mayo Clinic News Network

News Resources

Items tagged as "Journal of Clinical Oncology"

New Breast Cancer Risk Prediction Model More Accurate Than Current Model

New Breast Cancer Risk Prediction Model More Accurate Than Current Model

ROCHESTER, Minn. — A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the current screening standard. Results of a Mayo Clinic study comparing the new model to [...]

Created by Joe Dangor

Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening

Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening

  ROCHESTER, Minn. — Most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2, a Mayo Clinic-led study has found. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast [...]

Created by Joe Dangor

Mayo Clinic Study Finds Chromosomal Rearrangements Help Distinguish Between Independent Primary Tumors and Metastasis

Mayo Clinic Study Finds Chromosomal Rearrangements Help Distinguish Between Independent Primary Tumors and Metastasis

https://www.youtube.com/watch?v=ouOpv_tEIsU   ROCHESTER, Minn. — A diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung, a Mayo Clinic study has found. [...]

Created by Sam Smith

Trastuzumab (Herceptin) Continues to Show Life-Altering Benefit

Trastuzumab (Herceptin) Continues to Show Life-Altering Benefit

Years After Treatment for HER2-Positive Early Stage Breast Cancer Trastuzumab Shows Life-Altering Benefit  JACKSONVILLE, Fla. — After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer. They [...]

Created by Paul Scotti

Lymphoma Patients Event-Free Two Years after Diagnosis have a Normal Life Expectancy

Lymphoma Patients Event-Free Two Years after Diagnosis have a Normal Life Expectancy

http://www.youtube.com/watch?v=8jwdHjAnJCM ROCHESTER, Minn. — Feb. 18, 2014 — Newly-diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years after diagnosis have essentially the same life expectancy as they did prior to diagnosis, a Mayo Clinic study has found. Cancer related [...]

Created by Joe Dangor